These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 18763027

  • 1. Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial.
    Caproni M, Antiga E, Melani L, Volpi W, Del Bianco E, Fabbri P.
    J Clin Immunol; 2009 Mar; 29(2):210-4. PubMed ID: 18763027
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A multicenter, randomized, open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly, the combination of etanercept 25 mg twice weekly and acitretin, and acitretin alone in patients with moderate to severe psoriasis.
    Lee JH, Youn JI, Kim TY, Choi JH, Park CJ, Choe YB, Song HJ, Kim NI, Kim KJ, Lee JH, Yoo HJ.
    BMC Dermatol; 2016 Jul 25; 16(1):11. PubMed ID: 27455955
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The role of etanercept on the expression of markers of T helper 17 cells and their precursors in skin lesions of patients with psoriasis vulgaris.
    Antiga E, Volpi W, Chiarini C, Cardilicchia E, Filì L, Manuelli C, Parrochi P, Fabbri P, Caproni M.
    Int J Immunopathol Pharmacol; 2010 Jul 25; 23(3):767-74. PubMed ID: 20943046
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serum concentrations of interleukin-2 and tumour necrosis factor-α under cyclosporine versus acitretin treatment in plaque-type psoriasis.
    Akçali C, Guven EH, Kirtak N, Inaloz HS, Ozgoztasi O, Guvenc U.
    J Int Med Res; 2014 Oct 25; 42(5):1118-22. PubMed ID: 25143337
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Etanercept and recalcitrant acrodermatitis continua of Hallopeau.
    Nikkels AF, Piérard GE.
    J Drugs Dermatol; 2006 Sep 25; 5(8):705-6. PubMed ID: 16991229
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Novel combination regimens: biologics and acitretin for the treatment of psoriasis-- a case series.
    Conley J, Nanton J, Dhawan S, Pearce DJ, Feldman SR.
    J Dermatolog Treat; 2006 Sep 25; 17(2):86-9. PubMed ID: 16766332
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of psoriasis with different dosage regimens of etanercept: preliminary results from the Tαranta Plastic Study Group.
    Cassano N, Loconsole F, Miracapillo A, Travaglini M, Digiuseppe MD, Congedo M, Galluccio A, Buquicchio R, Mastrandrea V, Filieri M, Raho G, Pezza M, Vena GA.
    Int J Immunopathol Pharmacol; 2010 Sep 25; 23(3):797-802. PubMed ID: 20943050
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Failure of combination therapy with acitretin and cyclosporin A in 3 patients with erythrodermic psoriasis.
    Kuijpers AL, van Dooren-Greebe JV, van de Kerkhof PC.
    Dermatology; 1997 Sep 25; 194(1):88-90. PubMed ID: 9031805
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.